Andrew Skodyn has been quoted in an article from Law360Canada on the long-awaited decision in Pharmascience Inc. v. Janssen Inc, noting that the
In the decision, the Supreme Court of Canada confirmed that methods of medical treatment remain unpatentable under Canadian patent law, while clarifying that pharmaceutical dosing regimens may be patentable where they do not seek to monopolize professional medical skill and judgment.
The Court unanimously dismissed Pharmascience’s appeal and upheld the validity of Janssen’s patent covering dosing regimens for paliperidone, a long-acting injectable drug used to treat schizophrenia.
_
Read our full Comment on this decision here: “The More Things Change, The More They Stay the Same: The Supreme Court Determines the Patentability of Methods of Medical Treatment.”
Cassels lawyers Andrew Skodyn, Sean Jackson, and Eleanor Wilson represented the International Federation of Intellectual Property Attorneys (FICPI), an intervener in this appeal.